Skip to main navigation
About us
Our Approach
Our Pipeline
Patients
Investors
Careers
About us
Our Approach
Our Pipeline
Patients
Investors
Careers
Overview
Corporate Presentation
Overview
News & Events
News Releases
Events
Stock Information
Stock Quote & Chart
Analyst Coverage
Corporate Governance
Governance Overview
Board of Directors
Leadership
Financial Information
SEC Filings
SEC Filings - AGLE
Quarterly Results
IR Resources
Investor FAQs
Email Alerts
Contact IR

SEC Filing Details

Document Details

Form
10-Q
Filing Date
May 7, 2019
Document Date
Mar 31, 2019
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Spyre Therapeutics
Issuer
SPYRE THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
  • Our Approach
  • Approach
  • Therapeutic Targets
  • Half-life Extension
  • Rational Combinations
  • Publications
  • Our Programs
  • Pipeline
  • Programs
  • Investors
  • Corporate Presentation
  • Overview
  • News & Events
  • Stock Information
  • Financial Information
  • Corporate Governance
  • IR Resources
  • Patients
  • Spyre Commitment
  • Clinical Trials & Disease Ed
  • Careers
  • Values
  • Benefits
  • Careers
  • About Us
  • People
  • Contact
Subscribe
to stay updated
  • Terms of Service
  • Privacy Policy
© 2026 Spyre Therapeutics. All rights reserved. For U.S. residents only.
Design and development by Visual Science